Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 166
Filter
Add more filters

Publication year range
1.
J Neural Transm (Vienna) ; 124(2): 245-251, 2017 02.
Article in English | MEDLINE | ID: mdl-27816992

ABSTRACT

Causes of cardiovascular autonomic dysfunction in cervical dystonia (CD) are poorly understood. Studies examining effects of botulinum neurotoxin (BoNT) therapy on heart rate variability (HRV) yielded contradictory results. There is compelling evidence that depression shifts autonomic balance towards sympathetic predominance. As depression is the most frequent non-motor symptom in CD, we sought to determine if it is associated to dysfunction of cardiovascular autonomic regulation. Standardized interviews, clinical examinations, self-rating forms, autonomic symptom questionnaire, and automated autonomic testing in outpatients with idiopathic CD were used. Cardiovascular autonomic screening encompassed five different analyses of HRV, and testing of orthostasis. 85 CD patients participated in the study. 21% of them had HRV impairment, 14% orthostatic hypotension. 30% of CD patients had symptoms of depression. In those, decreased HRV was more frequent than in CD patients without mood disturbance (40 vs. 13%; p = 0.008). CD patients with and without depression had no other significant differences, including demographics, dystonia severity, comorbidity, medication, or BoNT therapy. Cardiovascular autonomic imbalance with sympathetic predominance is a non-motor manifestation of CD, associated to depression. Impaired HRV is a cardiovascular risk factor, moreover, emphasizing the need to identify and treat depression in dystonia.


Subject(s)
Depression/physiopathology , Heart Rate , Torticollis/physiopathology , Torticollis/psychology , Adult , Aged , Autonomic Nervous System Diseases/complications , Autonomic Nervous System Diseases/physiopathology , Autonomic Nervous System Diseases/psychology , Botulinum Toxins/therapeutic use , Cardiovascular Diseases/complications , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/psychology , Comorbidity , Depression/complications , Female , Heart Rate/physiology , Humans , Interviews as Topic , Male , Middle Aged , Neuromuscular Agents/therapeutic use , Self Report , Severity of Illness Index , Torticollis/complications , Torticollis/drug therapy
2.
Clin Auton Res ; 27(4): 279-282, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28674865

ABSTRACT

PURPOSE: To report the use of intranasal dexmedetomidine, an α2-adrenergic agonist for the acute treatment of refractory adrenergic crisis in patients with familial dysautonomia. METHODS: Case series. RESULTS: Three patients with genetically confirmed familial dysautonomia (case 1: 20-year-old male; case 2: 43-year-old male; case 3: 26-year-old female) received intranasal dexmedetomidine 2 mcg/kg, half of the dose in each nostril, for the acute treatment of adrenergic crisis. Within 8-17 min of administering the intranasal dose, the adrenergic crisis symptoms abated, and blood pressure and heart rate returned to pre-crises values. Adrenergic crises eventually resumed, and all three patients required hospitalization for investigation of the cause of the crises. CONCLUSIONS: Intranasal dexmedetomidine is a feasible and safe acute treatment for adrenergic crisis in patients with familial dysautonomia. Further controlled studies are required to confirm the safety and efficacy in this population.


Subject(s)
Adrenergic alpha-2 Receptor Agonists/therapeutic use , Autonomic Nervous System Diseases/drug therapy , Autonomic Nervous System Diseases/etiology , Dexmedetomidine/therapeutic use , Dysautonomia, Familial/complications , Dysautonomia, Familial/drug therapy , Administration, Intranasal , Adrenergic alpha-2 Receptor Agonists/administration & dosage , Adrenergic alpha-2 Receptor Agonists/adverse effects , Adrenergic alpha-Agonists/therapeutic use , Adult , Anxiety/psychology , Autonomic Nervous System Diseases/psychology , Blood Pressure/drug effects , Clonidine/therapeutic use , Dexmedetomidine/administration & dosage , Dexmedetomidine/adverse effects , Diazepam/therapeutic use , Drug Resistance , Dysautonomia, Familial/psychology , Female , GABA Modulators/therapeutic use , Heart Rate/drug effects , Humans , Male , Pneumonia, Mycoplasma/complications , Pneumonia, Mycoplasma/drug therapy , Young Adult
3.
J Neurol Neurosurg Psychiatry ; 87(2): 144-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25749693

ABSTRACT

INTRODUCTION: Orthostatic hypotension has been associated with impaired cognitive function, but cognitive function during orthostatic hypotension has hardly been studied. We studied the effect of orthostatic hypotension, induced by head-up tilt (HUT), on sustained attention in patients with autonomic failure. METHODS: We studied the sustained attention to response task (SART) in the supine position and during HUT in 10 patients with autonomic failure and 10 age-matched and sex-matched controls. To avoid syncope, the tilting angle was tailored to patients to reach a stable systolic blood pressure below 100 mm Hg. Controls were all tilted at an angle of 60°. Cerebral blood flow velocity, blood pressure and heart rate were measured continuously. RESULTS: In patients, systolic blood pressure was 61.4 mm Hg lower during HUT than in the supine position (p<0.001). Patients did not make more SART errors during HUT than in the supine position (-1.3 errors, p=0.3). Controls made 2.3 fewer errors during SART in the HUT position compared to the supine position (p=0.020). SART performance led to an increase in systolic blood pressure (+11.8 mm Hg, p=0.018) and diastolic blood pressure (+5.8 mm Hg, p=0.017) during SART in the HUT position, as well as to a trend towards increased cerebral blood flow velocity (+3.8 m/s, p=0.101). DISCUSSION: Orthostatic hypotension in patients with autonomic failure was not associated with impaired sustained attention. This might partly be explained by the observation that SART performance led to a blood pressure increase. Moreover, the upright position was associated with better performance in controls and, to a lesser extent, also in patients.


Subject(s)
Attention , Autonomic Nervous System Diseases/psychology , Shy-Drager Syndrome/psychology , Adult , Autonomic Nervous System Diseases/complications , Blood Pressure , Cerebrovascular Circulation , Female , Heart Rate , Humans , Male , Neuropsychological Tests , Reaction Time , Shy-Drager Syndrome/complications , Supine Position , Tilt-Table Test
4.
J Obstet Gynaecol Res ; 41(6): 912-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25546149

ABSTRACT

AIM: Autonomic nervous system activity was studied to evaluate the physical and mental state of women with unexplained recurrent pregnancy loss (RPL). METHODS: Heart rate variability (HRV) is a measure of beat-to-beat temporal changes in heart rate and provides indirect insight into autonomic nervous system tone and can be used to assess sympathetic and parasympathetic tone. We studied autonomic nervous system activity by measuring HRV in 100 women with unexplained RPL and 61 healthy female volunteers as controls. The degree of mental distress was assessed using the Kessler 6 (K6) scale. RESULTS: The K6 score in women with unexplained RPL was significantly higher than in control women. HRV evaluated on standard deviation of the normal-to-normal interval (SDNN) and total power was significantly lower in women with unexplained RPL compared with control women. These indices were further lower in women with unexplained RPL ≥4. On spectral analysis, high-frequency (HF) power, an index of parasympathetic nervous system activity, was significantly lower in women with unexplained RPL compared with control women, but there was no significant difference in the ratio of low-frequency (LF) power to HF power (LF/HF), an index of sympathetic nervous system activity, between the groups. CONCLUSIONS: The physical and mental state of women with unexplained RPL should be evaluated using HRV to offer mental support. Furthermore, study of HRV may elucidate the risk of cardiovascular diseases and the mechanisms underlying unexplained RPL.


Subject(s)
Abortion, Habitual/physiopathology , Autonomic Nervous System Diseases/etiology , Autonomic Nervous System/physiopathology , Embryo Loss/physiopathology , Abortion, Habitual/psychology , Adult , Anxiety/epidemiology , Anxiety/etiology , Autonomic Nervous System Diseases/epidemiology , Autonomic Nervous System Diseases/physiopathology , Autonomic Nervous System Diseases/psychology , Biomarkers , Depression/epidemiology , Depression/etiology , Embryo Loss/psychology , Female , Heart Rate , Hospitals, University , Humans , Japan/epidemiology , Recurrence , Risk Factors , Young Adult
5.
Cardiology ; 127(1): 1-19, 2014.
Article in English | MEDLINE | ID: mdl-24157651

ABSTRACT

The need for addressing posttraumatic stress disorder (PTSD) among combat veterans returning from Afghanistan and Iraq is a growing public health concern. Current PTSD management addresses psychiatric parameters of this condition. However, PTSD is not simply a psychiatric disorder. Traumatic stress increases the risk for inflammation-related somatic diseases and early mortality. The metabolic syndrome reflects the increased health risk associated with combat stress and PTSD. Obesity, dyslipidemia, hypertension, diabetes mellitus, and cardiovascular disease are prevalent among PTSD patients. However, there has been little appreciation for the need to address these somatic PTSD comorbidities. Medical professionals treating this vulnerable population should screen patients for cardiometabolic risk factors and avail themselves of existing preventive diet, exercise, and pharmacologic modalities that will reduce such risk factors and improve overall long-term health outcomes and quality of life. There is the promise that cardiometabolic preventive therapy complementing psychiatric intervention may, in turn, help improve the posttraumatic stress system dysregulation and favorably impact psychiatric and neurologic function. © 2013 S. Karger AG, Basel.


Subject(s)
Metabolic Syndrome/psychology , Stress Disorders, Post-Traumatic/complications , Arousal/physiology , Autonomic Nervous System Diseases/psychology , Blood Coagulation Disorders/psychology , Coronary Disease/psychology , Diabetes Complications/psychology , Dyslipidemias/psychology , Endoplasmic Reticulum Stress/physiology , Health Status , Humans , Inflammation/physiopathology , Insulin Resistance/physiology , Mental Healing , Mental Health , Metabolic Syndrome/mortality , Mortality, Premature , Neuropeptide Y/physiology , Neurosecretory Systems/physiology , Neurotransmitter Agents/physiology , Obesity/psychology , Risk Factors , Sleep Wake Disorders/psychology , Stress Disorders, Post-Traumatic/mortality , Stress Disorders, Post-Traumatic/therapy , Suicide/psychology , Weight Gain/physiology
6.
Clin Auton Res ; 23(4): 169-73, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23761114

ABSTRACT

OBJECTIVE: To describe and review autonomic complications of lightning strike. METHODS: Case report and laboratory data including autonomic function tests in a subject who was struck by lightning. RESULTS: A 24-year-old man was struck by lightning. Following that, he developed dysautonomia, with persistent inappropriate sinus tachycardia and autonomic storms, as well as posttraumatic stress disorder (PTSD) and functional neurologic problems. INTERPRETATION: The combination of persistent sinus tachycardia and episodic exacerbations associated with hypertension, diaphoresis, and agitation was highly suggestive of a central hyperadrenergic state with superimposed autonomic storms. Whether the additional PTSD and functional neurologic deficits were due to a direct effect of the lightning strike on the central nervous system or a secondary response is open to speculation.


Subject(s)
Autonomic Nervous System Diseases/etiology , Lightning Injuries/complications , Activities of Daily Living , Adrenergic alpha-Agonists/therapeutic use , Anxiety/etiology , Arrhythmias, Cardiac/etiology , Autonomic Nervous System Diseases/physiopathology , Autonomic Nervous System Diseases/psychology , Burns/etiology , Burns/pathology , Case Management , Clonidine/therapeutic use , Humans , Lightning Injuries/physiopathology , Lightning Injuries/psychology , Male , Neurologic Examination , Pain/etiology , Primary Dysautonomias/etiology , Psychomotor Agitation/etiology , Recovery of Function , Sleep Initiation and Maintenance Disorders/etiology , Stress Disorders, Post-Traumatic/complications , Stress Disorders, Post-Traumatic/physiopathology , Treatment Failure , Young Adult
7.
Lupus ; 21(10): 1128-30, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22460293

ABSTRACT

The psychiatric manifestations of three patients with systemic lupus erythematosus (SLE) and neuropathic dysautonomic processes are described. All patients had a severe form of SLE with neurological, renal, articular, pulmonary or haematological manifestations. All three have two types of psychiatric manifestations: (1) a chronic and progressive depression and (2) a complex dissociative disorder during the acute episodes of postural hypotension. A provocative test with SPECT with 99mTc-HmPAO to be done during the episode of orthostatic hypotension may contribute to clinical assessment of complex changes in cerebral regional perfusion.


Subject(s)
Autonomic Nervous System Diseases/etiology , Autonomic Nervous System Diseases/psychology , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/psychology , Adolescent , Autoimmune Diseases of the Nervous System/diagnostic imaging , Autoimmune Diseases of the Nervous System/etiology , Autoimmune Diseases of the Nervous System/psychology , Autonomic Nervous System Diseases/diagnostic imaging , Brain/blood supply , Brain/diagnostic imaging , Cerebrovascular Circulation , Depression/diagnostic imaging , Depression/etiology , Depression/psychology , Dissociative Disorders/diagnostic imaging , Dissociative Disorders/etiology , Dissociative Disorders/psychology , Female , Humans , Hypotension, Orthostatic/diagnostic imaging , Hypotension, Orthostatic/etiology , Hypotension, Orthostatic/psychology , Lupus Erythematosus, Systemic/diagnostic imaging , Radiopharmaceuticals , Technetium Tc 99m Exametazime , Tomography, Emission-Computed, Single-Photon , Young Adult
8.
BJOG ; 119(1): 40-50, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22008610

ABSTRACT

OBJECTIVE: Hot flushes and night sweats (HFs/NSs) are the main menopausal symptoms, but few studies have been adequately powered to examine the dimensions or predictors of experiencing HFs/NSs. We report on these variables in a large UK cohort of postmenopausal women. DESIGN: Cross-sectional cohort study. SETTING: UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) cohort. POPULATION: A cohort of 202,638 postmenopausal women, aged 50-74 years, without oophorectomy, recruited to UKCTOCS between 2001 and 2005. METHODS: Women completed a follow-up questionnaire, and those aged 54-65 years were mailed a survey in July 2008. MAIN OUTCOME MEASURES: Hot flush prevalence and hot flush rating scale. RESULTS: Of the 15,000 women mailed, 10,418 returned completed questionnaires; 90% had previously had HFs/NSs. Despite being on average 10 years postmenopausal, 54% experienced HFs/NSs (frequency of 33 per week with mean problem rating 4/10) that persisted across the age range. Past hysterectomy (OR 1.50, 95% CI 1.19-1.86), ever having smoked (OR 1.27, 95% CI 1.11-1.46) and alcohol consumption (current units) (OR 1.05, 95% CI 1.01-1.09) predicted ever having had HFs/NSs. Anxiety (OR 3.09, 95% CI 2.57-3.72), hysterectomy (OR 2.74, 95% CI 2.32-3.25), depressed mood (OR 1.57, 95% CI 1.24-1.99), years since last menstrual period (OR 0.95, 95% CI 0.94-0.96) and education (above and below 18 years) (OR 0.98, 95% CI 0.97-0.99) predicted the current prevalence of HFs/NSs. Few predictors of frequency were identified, but problem rating was associated with depressed mood, hysterectomy, skirt size increase and frequency of HFs/NSs. Past hormone therapy users who had discontinued treatment were more likely to have HFs/NSs that were more frequent and problematic. CONCLUSIONS: To date, this is the largest UK study of the experience of HFs/NSs amongst older postmenopausal women. HFs/NSs are more prevalent in this age band than has previously been assumed. These findings and the associations of smoking, hysterectomy, anxiety, depressed mood and hormone therapy use with the experience of HFs/NSs have implications for prevention and symptom management.


Subject(s)
Attitude to Health , Hot Flashes/psychology , Postmenopause/psychology , Affect , Age Factors , Aged , Autonomic Nervous System Diseases/epidemiology , Autonomic Nervous System Diseases/psychology , Body Mass Index , Cross-Sectional Studies , Female , Hormone Replacement Therapy/psychology , Hot Flashes/epidemiology , Humans , Hyperhidrosis/epidemiology , Hyperhidrosis/psychology , Hysterectomy/psychology , Life Style , Middle Aged , Prevalence , Surveys and Questionnaires , United Kingdom/epidemiology , Vasomotor System/physiology
9.
Fortschr Neurol Psychiatr ; 80(1): 29-35, 2012 Jan.
Article in German | MEDLINE | ID: mdl-22173967

ABSTRACT

Anti-NMDA receptor encephalitis is a severe autoimmune disease, first described in 2007.  Since then a number of cases have been published, suggesting that to date the disease is a considerably underdiagnosed entity. The clinical picture develops over a relatively long period of time and is initially characterised by psychiatric symptoms such as decreased levels of consciousness and hallucinations as well as paranoid behaviour. In the course of the disease neurological symptoms occur, in particular, seizures, autonomic dysfunction and dyskinesias. Due to the young age of many patients, the symptoms are often mistaken as to result from drug-induced psychosis. Anti-NMDA receptor Encephalitis was first described in young women with teratomas. In the past few years the disorder has also been reported in men and children and without any detectable neoplasia. The diagnosis is based on the characteristic clinical picture and supportive findings in MRI, EEG and the cerebrospinal fluid. Hereby, highly specific autoantibodies directed against the NR1 subunit of the NMDA-type glutamate receptors in the CSF (or serum) play an important role and should be sought specifically in any case of an "encephalitis of unknown cause". The prognosis of the disease is favourable, even when autonomic disorders entail ventilation and/or prolonged intensive care treatment is necessary. Nonetheless, the clinical outcome is highly dependent on an early diagnosis and immunotherapy without delay. In the case of a malignancy, tumour removal is also crucial. Taken together, an interdisciplinary approach including neurologists, psychiatrists, oncologists and gynaecologists is essential in order to detect and effectively treat this disorder.


Subject(s)
Autoimmune Diseases/psychology , Autoimmune Diseases/therapy , Emergency Medical Services , Limbic Encephalitis/psychology , Limbic Encephalitis/therapy , Receptors, N-Methyl-D-Aspartate/immunology , Adult , Autoimmune Diseases/diagnosis , Autonomic Nervous System Diseases/etiology , Autonomic Nervous System Diseases/psychology , Cognition Disorders/etiology , Cognition Disorders/psychology , Dyskinesias/etiology , Dyskinesias/psychology , Electroencephalography , Epilepsy/etiology , Epilepsy/psychology , Humans , Immunosuppressive Agents/therapeutic use , Limbic Encephalitis/diagnosis , Limbic Encephalitis/etiology , Magnetic Resonance Imaging , Male , Neurology , Psychiatry
10.
Health Qual Life Outcomes ; 9: 85, 2011 Sep 30.
Article in English | MEDLINE | ID: mdl-21961625

ABSTRACT

BACKGROUND: Cancer Related Fatigue (CRF) and circadian rhythm have a great impact on the quality of life (HRQL) of patients with breast (BC) and colon cancer (CRC). Other patient related outcomes in oncology are measured by new instruments focusing on adaptive characteristics such as sense of coherence or self-regulation, which could be more appropriate as a prognostic tool than classical HRQL. The aim of this study was to assess the association of autonomic regulation (aR) and self-regulation (SR) with survival. METHODS: 146 cancer patients and 120 healthy controls took part in an initial evaluation in 2000/2001. At a median follow up of 5.9 years later, 62 of 95 BC, 17 of 51 CRC patients, and 85 of 117 healthy controls took part in the follow-up study. 41 participants had died. For the follow-up evaluation, participants were requested to complete the standardized aR and SR questionnaires. RESULTS: On average, cancer patients had survived for 10.1 years with the disease. Using a Cox proportional hazard regression with stepwise variables such as age, diagnosis group, Charlson co-morbidity index, body mass index (BMI)) aR and SR. SR were identified as independent parameters with potential prognostic relevance on survival While aR did not significantly influence survival, SR showed a positive and independent impact on survival (OR = 0.589; 95%-CI: 0.354 - 0.979). This positive effect persisted significantly in the sensitivity analysis of the subgroup of tumour patients and in the subscale 'Achieve satisfaction and well-being' and by tendency in the UICC stages nested for the different diagnoses groups. CONCLUSIONS: Self-regulation might be an independent prognostic factor for the survival of breast and colon carcinoma patients and merits further prospective studies.


Subject(s)
Autonomic Nervous System Diseases/psychology , Breast Neoplasms/psychology , Colonic Neoplasms/psychology , Quality of Life , Anxiety Disorders/psychology , Case-Control Studies , Comorbidity , Depressive Disorder/psychology , Female , Humans , Male , Middle Aged , Observation , Prognosis , Proportional Hazards Models , Prospective Studies , Surveys and Questionnaires , Survival Rate
11.
Med Tr Prom Ekol ; (2): 38-42, 2011.
Article in Russian | MEDLINE | ID: mdl-21506377

ABSTRACT

Human evolution is accompanied by "sensible thoughts" spread to all spheres of occupational activities. One can hardly find an industrial enterprise without computers. In contemporary industry, health care in conditions of humans and computers interaction and evaluation of harm in computer users remain topical. Social and occupational environment is not always comfortable for human body. Changes is occupational conditions, with wide use of computer technologies, decrease role of manual labour and increase role of intellectual work from the one hand, but from the other hand, chasing economic profit alters individual "comfort zone" due to constant psychoemotional stress and causes "burnout". Being healthy in constant stress is impossible.


Subject(s)
Autonomic Nervous System Diseases/etiology , Autonomic Nervous System/physiology , Computers , Occupational Diseases/etiology , Occupational Health , Workplace/standards , Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System Diseases/psychology , Female , Humans , Male , Occupational Diseases/diagnosis , Occupational Diseases/psychology , Stress, Psychological/physiopathology , Surveys and Questionnaires
12.
J Autism Dev Disord ; 51(1): 144-157, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32410097

ABSTRACT

Autism spectrum disorder (ASD) is a complex neurological and developmental disorder, and a growing body of literature suggests the presence of autonomic nervous system (ANS) dysfunction in individuals with ASD. ANS is part of the "gut brain axis", which consists of an intricate interplay between the gut microbiome, mucosal immune system, enteric nervous system, ANS, and central processes receiving input from the vagus nerve. Measurements of the gut microbiome and the autonomic indices can serve as non-invasive markers of the status of the gut-brain axis in ASD. To our knowledge, no previous studies have explored the relationship between ANS and gut microbiome in individuals with ASD. Furthermore, while previous studies investigated the use of autonomic indices and gut microbiome independently as markers of ASD-related comorbidities, such as anxiety, cardiovascular issues, and gastrointestinal dysfunction, the use of combined autonomic indices and gut microbiome factors to classify ASD and control subjects has not been explored. In this study, we characterized autonomic function of a group of individuals with ASD in comparison to their paired, first-degree relative controls. Second, we explored the ASD gut-brain-axis through the relationship between gut microbiome markers and autonomic indices, as well as the correlation between the gut-brain-axis and clinical presentation of ASD. Lastly, this study explores the predictive capability of gut-brain-axis biomarkers (including autonomic and microbiome indices) in subtyping ASD cases, serving as a starting point to investigate the possibility of assisting in ASD screening and diagnosis that still heavily relies on psychological testing, which may be based on highly subjective standards.


Subject(s)
Autism Spectrum Disorder/diagnosis , Autism Spectrum Disorder/physiopathology , Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System Diseases/physiopathology , Gastrointestinal Microbiome/physiology , Mass Screening/methods , Adolescent , Adult , Autism Spectrum Disorder/psychology , Autonomic Nervous System Diseases/psychology , Brain/physiopathology , Child , Female , Gastrointestinal Diseases/diagnosis , Gastrointestinal Diseases/physiopathology , Gastrointestinal Diseases/psychology , Humans , Male , Psychological Tests , Young Adult
13.
Arab J Gastroenterol ; 21(1): 32-36, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32088164

ABSTRACT

BACKGROUND AND STUDY AIMS: Cirrhosis is a multisystem disorder characterized by hyperdynamic circulation which can progress to multiple organ dysfunctions. Recent studies have demonstrated autonomic dysfunction and cirrhotic cardiomyopathy including diastolic dysfunction, systolic dysfunction with electrophysiologic abnormalities in patients with cirrhosis. Due to the long and complicated course of the disease, health related quality of life is affected. We aimed to evaluate the frequency of diastolic dysfunction and autonomic dysfunction in cirrhosis, and the effects on health-related quality of life. PATIENTS AND METHODS: Hundred cirrhotic patients were enrolled in the study. According to the Child-Pugh classification 35 patients were of Child A, 36 of Child B and 29 of Child C. The proportion of autonomic dysfunction was 52%, and diastolic dysfunction 51%. Autonomic dysfunction was diagnosed using bedside maneuvers and tests; diastolic dysfunction was diagnosed using the E/A ratio in echocardiographic findings. Health-related quality of life measurements was obtained from an SF-36 questionnaire. RESULTS: Patients with advanced Child-Pugh classifications were found to have significantly lower health-related quality of life values (p < 0.05). Likewise, health-related quality of life values were observed to be significantly lower in patients with autonomic dysfunction (p < 0.05). No significant difference was found in health related quality of life measurements between patients with and without diastolic dysfunction. CONCLUSION: Our study showed that autonomic dysfunction and diastolic dysfunction are found in patients with cirrhosis. Further studies are needed to assess the effects of autonomic dysfunction and diastolic dysfunction on health-related quality of life.


Subject(s)
Autonomic Nervous System Diseases/epidemiology , Cardiomyopathies/epidemiology , Liver Cirrhosis/complications , Liver Cirrhosis/physiopathology , Quality of Life , Aged , Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System Diseases/psychology , Blood Pressure , Cardiomyopathies/diagnosis , Cardiomyopathies/psychology , Cohort Studies , Female , Heart Rate , Humans , Liver Cirrhosis/psychology , Male , Middle Aged , Turkey
14.
J Diabetes Investig ; 11(6): 1388-1402, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32403204

ABSTRACT

Impaired awareness of hypoglycemia (IAH) is a reduction in the ability to recognize low blood glucose levels that would otherwise prompt an appropriate corrective therapy. Identified in approximately 25% of patients with type 1 diabetes, IAH has complex pathophysiology, and might lead to serious and potentially lethal consequences in patients with diabetes, particularly in those with more advanced disease and comorbidities. Continuous glucose monitoring systems can provide real-time glucose information and generate timely alerts on rapidly falling or low blood glucose levels. Given their improvements in accuracy, affordability and integration with insulin pump technology, continuous glucose monitoring systems are emerging as critical tools to help prevent serious hypoglycemia and mitigate its consequences in patients with diabetes. This review discusses the current knowledge on IAH and effective diagnostic methods, the relationship between hypoglycemia and cardiovascular autonomic neuropathy, a practical approach to evaluating cardiovascular autonomic neuropathy for clinicians, and recent evidence from clinical trials assessing the effects of the use of CGM technologies in patients with type 1 diabetes with IAH.


Subject(s)
Autonomic Nervous System Diseases/etiology , Diabetes Complications/etiology , Diabetes Mellitus/physiopathology , Diabetic Neuropathies/etiology , Health Knowledge, Attitudes, Practice , Hypoglycemia/complications , Autonomic Nervous System Diseases/pathology , Autonomic Nervous System Diseases/psychology , Blood Glucose Self-Monitoring , Diabetes Complications/pathology , Diabetes Complications/psychology , Diabetic Neuropathies/pathology , Diabetic Neuropathies/psychology , Humans , Hypoglycemia/pathology , Hypoglycemia/psychology , Prognosis , Risk Factors
15.
J Diabetes Complications ; 34(8): 107617, 2020 08.
Article in English | MEDLINE | ID: mdl-32546420

ABSTRACT

AIMS: To investigate the relationship of unawareness of hypoglycemia with spectral analysis of heart rate variability (HRV) and clinical variables in type 1 diabetes (T1D) individuals. METHODS: Participants with type 1 diabetes mellitus (type 1 diabetes) were prospectively assessed for hypoglycemia awareness using the Pedersen-Bjergaard method and were classified as normal hypoglycemia awareness, impaired hypoglycemia awareness and hypoglycemia unawareness. Indices of HRV in frequency domain were evaluated and Ewing tests were used for the diagnosis of cardiovascular autonomic neuropathy (CAN). RESULTS: Ninety-eight participants with T1D (mean age 26 years, average diabetes duration 13 years, and mean HbA1c 8.4%) were included in this study. The prevalence of hypoglycemia unawareness was 28%. No significant difference was observed on the prevalence of CAN among groups of different hypoglycemia awareness (p = 0.740). On regression analyses, abnormal results of HRV in frequency domain were not associated with unawareness of hypoglycemia. On univariable regression analysis, age, diabetes duration and estimated creatinine clearance were associated with unawareness of hypoglycemia. CONCLUSION: CAN as assessed by Ewing tests and spectral analysis of HRV is not associated with unawareness of hypoglycemia. There is association of age, diabetes duration and renal deficit with unawareness of hypoglycemia.


Subject(s)
Autonomic Nervous System Diseases/diagnosis , Awareness , Diabetes Mellitus, Type 1/complications , Diabetic Neuropathies/diagnosis , Heart Rate/physiology , Hypoglycemia/psychology , Adolescent , Adult , Autonomic Nervous System Diseases/etiology , Autonomic Nervous System Diseases/psychology , Diabetes Mellitus, Type 1/physiopathology , Diabetes Mellitus, Type 1/psychology , Diabetic Neuropathies/etiology , Diabetic Neuropathies/psychology , Female , Humans , Hypoglycemia/diagnosis , Hypoglycemia/etiology , Male , Middle Aged , Prospective Studies , Young Adult
16.
Neurochem Int ; 141: 104890, 2020 12.
Article in English | MEDLINE | ID: mdl-33122033

ABSTRACT

Alzheimer's disease is a multifactorial neurodegenerative condition manifested through acute cognitive decline, amyloid plaque deposits and neurofibrillary tangles. Complete cure for this disease remains elusive as the conventional drugs address only a single molecular target while Alzheimer's disease involves a complex interplay of different sets of molecular targets and signaling networks. In this context, the possibility of employing multi-drug combinations to rescue neurons from the dysregulated metabolic changes is being actively investigated. The present work investigates a poly-herbal formulation, Brahmi Nei that has been traditionally used for anxiolytic disorders and immunomodulatory effects, for its efficiency in ameliorating cognitive decline through a combination of behavioral, biochemical, histopathological, gene and protein expression analyses. Our results reveal that the formulation shows excellent neuroregenerative properties, rescues neurons from inflammatory damage, reduces neuritic plaque deposits and improves working memory in rodent models with scopolamine-induced dementia. The microarray analysis shows that the formulation induces the expression of pro-survival pathways and positively modulates genes involved in memory consolidation, axonal growth and proliferation in a concentration-dependent manner with therapeutic concentrations restoring the normal conditions in the brain of the diseased animals. The neuritic spine morphology confirms the long-term memory potentiation through improved mushroom spine density, increased dendritic length and connectivity. Taken together, our study provides mechanistic evidence to prove that the traditional formulation can be a superior therapeutic strategy to treat cognitive decline when compared to the conventional mono-drug treatment.


Subject(s)
Autonomic Nervous System Diseases/drug therapy , Autonomic Nervous System Diseases/psychology , Cognition Disorders/drug therapy , Cognition Disorders/psychology , Herbal Medicine , Animals , Autonomic Nervous System Diseases/complications , Axons/drug effects , Axons/pathology , Cell Proliferation/drug effects , Cell Survival/drug effects , Cognition Disorders/etiology , Dendrites/drug effects , Dendrites/ultrastructure , Dose-Response Relationship, Drug , Drug Combinations , Drug Compounding , Male , Maze Learning/drug effects , Memory, Short-Term/drug effects , Nerve Regeneration/drug effects , Neurites/pathology , Phytotherapy , Rats , Rats, Wistar
17.
J Neuropsychiatry Clin Neurosci ; 21(2): 126-31, 2009.
Article in English | MEDLINE | ID: mdl-19622683

ABSTRACT

Agrypnia excitata is an extremely rare, life-threatening syndrome characterized by autonomic activation, persistent insomnia, and generalized overactivity. Agrypnia excitata describes a triad of three separate conditions: delirium tremens, Morvan's chorea, and familial fatal insomnia (FFI). Each of the aforementioned three conditions have sleep disturbances as a unifying theme and results in distinct neurophysiological findings. The following is an overview of agrypnia excitata with a particular emphasis placed upon each of the three individual conditions that constitute the syndrome with recommendations on appropriate management.


Subject(s)
Autonomic Nervous System Diseases/therapy , Cognition Disorders/therapy , Insomnia, Fatal Familial/therapy , Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System Diseases/psychology , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Disease Management , Forecasting , Humans , Insomnia, Fatal Familial/diagnosis , Insomnia, Fatal Familial/psychology , Myokymia/diagnosis , Myokymia/psychology , Myokymia/therapy
18.
BMC Musculoskelet Disord ; 10: 63, 2009 Jun 07.
Article in English | MEDLINE | ID: mdl-19500420

ABSTRACT

BACKGROUND: Repetitive and stressful work tasks have been linked to the development of pain in the trapezius muscle, although the underlying mechanisms still remain unclear. In earlier studies, it has been hypothesized that chronic muscle pain conditions are associated with imbalance in the autonomic nervous system, predominantly expressed as an increased sympathetic activity. This study investigates whether women with chronic trapezius myalgia show higher muscle activity and increased sympathetic tone at baseline and during repetitive low-force work and psychosocial stress, compared with pain-free controls. METHODS: Eighteen women with chronic trapezius myalgia (MYA) and 30 healthy female controls (CON) were studied during baseline rest, 100 min of repetitive low-force work, 20 min of psychosocial stress (Trier Social Stress Test, TSST), and 80 min recovery. The subjects rated their pain intensity, stress and energy level every 20 min throughout the experiment. Muscle activity was measured by surface electromyography in the trapezius muscle (EMGtrap) and deltoid muscle (EMGdelt). Autonomic reactivity was measured through heart rate (HR), skin conductance (SCL), blood pressure (MAP) and respiration rate (Resp). RESULTS: At baseline, EMGtrap, stress ratings, and HR were higher in MYA than in CON. Energy ratings, EMGdelt, SCL, MAP and Resp were, however, similar in the two groups. Significant main group effects were found for pain intensity, stress ratings and EMGtrap. Deltoid muscle activity and autonomic responses were almost identical in MYA and CON during work, stress and recovery. In MYA only, pain intensity and stress ratings increased towards the end of the repetitive work. CONCLUSION: We found increased muscle activity during uninstructed rest in the painful muscle of a group of women with trapezius myalgia. The present study could not confirm the hypothesis that chronic trapezius myalgia is associated with increased sympathetic activity. The suggestion of autonomic imbalance in patients with chronic local or regional musculoskeletal pain needs to be further investigated.


Subject(s)
Muscle Contraction/physiology , Muscle, Skeletal/physiopathology , Muscular Diseases/physiopathology , Occupational Diseases/physiopathology , Pain, Intractable/physiopathology , Stress, Psychological/complications , Adult , Autonomic Nervous System Diseases/diagnosis , Autonomic Nervous System Diseases/physiopathology , Autonomic Nervous System Diseases/psychology , Back/physiopathology , Chronic Disease/psychology , Cumulative Trauma Disorders/physiopathology , Cumulative Trauma Disorders/psychology , Disability Evaluation , Electromyography , Exercise Tolerance/physiology , Female , Humans , Middle Aged , Muscle, Skeletal/innervation , Muscular Diseases/etiology , Muscular Diseases/psychology , Occupational Diseases/psychology , Pain, Intractable/etiology , Pain, Intractable/psychology , Physical Fitness/physiology , Rest/physiology , Rest/psychology , Shoulder/physiopathology , Stress, Psychological/physiopathology , Stress, Psychological/psychology , Sympathetic Fibers, Postganglionic/physiopathology
19.
Psychiatr Danub ; 21(4): 483-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19935481

ABSTRACT

BACKGROUND: Vehicle accidents are a common cause of disease and death among people over 30 years of age. Essentially, reaction to stress due to the vehicle accident does not differ from the reaction to other stress factors. There are still no uniform viewpoints about the kind of sequels and their percentage representation after vehicle accidents. SUBJECTS AND METHODS: The research was provided as a prospective study, included 150 subjects who had vehicle accident minimum 2 years prior to the examination. A questionnaire adjusted to the needs of the research and a battery of psychological tests was used. RESULTS: Affective disorders occurred in 35.33% of subjects, 65% of persons suffer from travel anxiety, 9% of the total number of examinees doesn't drive any more, 65% have somatisational dysfunctions of the vegetative nervous system, while the posttraumatic stress disorder is present in 36% of subjects. CONCLUSION: In 87.4% of persons psychiatric consequences last over two years. Long term consequences in 60% of subjects occur as a combination of multiple psychiatric disorders, so the posttraumatic stress disorder and affective disorders never occur one at a time.


Subject(s)
Accidents, Traffic/psychology , Anxiety Disorders/diagnosis , Autonomic Nervous System Diseases/diagnosis , Depressive Disorder/diagnosis , Life Change Events , Psychophysiologic Disorders/diagnosis , Somatoform Disorders/diagnosis , Stress Disorders, Post-Traumatic/diagnosis , Adaptation, Psychological , Adult , Age Factors , Anxiety Disorders/epidemiology , Anxiety Disorders/psychology , Automobile Driving/psychology , Autonomic Nervous System Diseases/epidemiology , Autonomic Nervous System Diseases/psychology , Comorbidity , Cross-Sectional Studies , Depressive Disorder/epidemiology , Depressive Disorder/psychology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Personality Inventory , Prospective Studies , Psychophysiologic Disorders/epidemiology , Psychophysiologic Disorders/psychology , Serbia , Sex Factors , Social Adjustment , Somatoform Disorders/epidemiology , Somatoform Disorders/psychology , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/psychology , Wounds and Injuries/psychology , Young Adult
20.
Turk Kardiyol Dern Ars ; 37(4): 226-33, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19717954

ABSTRACT

OBJECTIVES: This study aimed to assess autonomic dysfunction parameters and anxiety levels in patients with mitral valve prolapse (MVP). STUDY DESIGN: We evaluated 33 patients (mean age 25+/-5 years) with MVP and 14 healthy subjects (mean age 25+/-4 years). The patients were divided into two groups according to the presence (anatomical MVP, n=11) or absence (MVP syndrome, n=22) of abnormal leaflet thickening (>5 mm). Spielberger's Situational Anxiety Scale (SSAS) and Continuous Anxiety Scale (SCAS) were administered to all the subjects, and heart rates (HR) and arterial blood pressures (BP) were measured in the supine and standing positions. RESULTS: Mid-systolic click and late systolic murmur were significantly more frequent in patients with anatomical MVP, while nonspecific symptoms such as dyspnea, vertigo, and atypical chest pain were more frequent in patients with MVP syndrome (p<0.05). Mitral insufficiency (mild) was significantly more frequent in patients with anatomical MVP (72.7% vs. 22.7%; p<0.009). Patients with MVP syndrome had significantly higher SSAS and SCAS scores (41.0+/-15.6 and 38.5+/-15.5) compared to patients with anatomical MVP (15.8+/-7.5 and 17.0+/-9.1) and controls (14.9+/-7.4 and 16.9+/-8.7, respectively; for both p<0.001). Orthostatic differences in BP and HR were significantly greater in patients with MVP syndrome than those having anatomical MVP (p<0.001 and p=0.032, respectively). Orthostatic HR differences showed a significant correlation with SSAS in both MVP groups (r=0.536, p=0.001) and a significant correlation with SCAS in patients with MVP syndrome (r=0.523, p=0.002). There was an inverse correlation between orthostatic BP differences and anxiety parameters in all MVP patients (r=-0.391, p=0.025 for SSAS, and r=-0.320, p=0.048 for SCAS). CONCLUSION: Our data suggest that patients with MVP syndrome have increased autonomic dysfunction and anxiety scores compared to patients with anatomical MVP.


Subject(s)
Mitral Valve Prolapse/physiopathology , Mitral Valve Prolapse/psychology , Adult , Anxiety , Autonomic Nervous System Diseases/physiopathology , Autonomic Nervous System Diseases/psychology , Blood Pressure , Electrocardiography , Female , Heart Murmurs/physiopathology , Heart Murmurs/psychology , Heart Rate , Humans , Interviews as Topic , Male , Psychiatric Status Rating Scales , Reference Values , Systole , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL